G. Morgan, C. Backinger, C. Lerman
May 1, 2010
Citations
0
Influential Citations
5
Citations
Quality indicators
Journal
American journal of health behavior
Abstract
OBJECTIVE To review the current state of the science in medication development for nicotine dependence and to identify important areas for future research. METHODS The National Cancer Institute and the National Institute on Drug Abuse convened a conference focused on translational approaches to the development, evaluation, and delivery of medications for the treatment of tobacco dependence. RESULTS Future research directions include investigations of the efficacy of novel compounds and new applications for existing medications; pharmacogenetic trials of nicotine dependence treatments; and studies of the molecular, neural, and behavioral mechanisms of action of efficacious medications. CONCLUSIONS Medication development for the treatment of tobacco dependence remains a scientific and public health priority.